Itraconazole antagonizes store‐operated influx of calcium into chemoattractant‐activated human neutrophils
Author(s) -
STEEL H. C.,
ANDERSON R.
Publication year - 2004
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.2004.02443.x
Subject(s) - itraconazole , calcium , cytosol , chemistry , in vivo , pharmacology , homeostasis , intracellular , immunology , inositol , biochemistry , microbiology and biotechnology , biology , receptor , antifungal , enzyme , organic chemistry
SUMMARY We have investigated the effects of itraconazole (0·1–10 µ m ), an antimycotic which is often used prophylactically in primary and secondary immunodeficiency disorders, including chronic granulomatous disease, on mobilization of Ca 2+ and restoration of Ca 2+ homeostasis following activation of neutrophils with FMLP or PAF. Transmembrane fluxes of Ca 2+ , as well as cytosolic concentrations of the cation were measured using a combination of spectrofluorimetric and radiometric procedures. The abruptly occurring increases in cytosolic Ca 2+ following activation of the cells with either FMLP (1 µ m ) or PAF (200 n m ) were unaffected by itraconazole. However, the subsequent store‐operated influx of the cation was attenuated by itraconazole at concentrations of 0·25 µ m and higher. The itraconazole‐mediated inhibition of uptake of Ca 2+ was not associated with detectable alterations in the intracellular concentrations of cyclic AMP, ATP or inositol triphosphate, and appeared to be compatible with antagonism of store‐operated Ca 2+ channels. Although a secondary property, this anti‐inflammatory activity of itraconazole, if operative in vivo , may be beneficial in conditions associated with dysregulation of neutrophil Ca 2+ handling such as CGD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom